Seborrheic keratosis: clinical characteristics and an association with the β-genus human papillomavirus

Cover Page


Cite item

Full Text

Abstract

Background: Seborrheic keratosis is a  common benign tumor of unclear etiology. Aim: To study associations between clinical characteristics of seborrheic keratosis and its course with quantitative parameters of the β-genus human papillomavirus (β-HPV). Materials and methods: The main study group included 91 patients with seborrheic keratosis (29 male and 62 female), aged 40 to 75  years (mean ± SD, 59.2 ± 6.4 years). The control group included 30 healthy individuals persons aged 40 to 70 years (mean 57.6 ± 4.1 years). The diagnosis of seborrheic keratosis was confirmed by dermoscopy and pathomorphological assessment, with 100% of patients having the acanthotic type of seborrheic keratosis. HPV was identified by polymerase chain reaction with hybridization fluorescent detection in real time mode with use of three oligonucleotide systems for detection of HPV genus β1 (subtypes 5, 8, 12, 14, 19, 21, 25, 36, 47); β2 (subtypes 9, 15, 17, 22, 23, 37, 38, 80), and β3 (subtypes 49, 75, 76). Results: The most frequent clinical type of seborrheic keratosis was the maculopapular one (61/91 patients, 67%) localized mainly on head, neck, anterior and posterior trunk. β-HPV was found in 88.8% biopsy samples taken from the seborrheic keratosis areas in 24 of 27 patients and in 66.6% biopsy samples taken from the normal skin areas of the same patients (р = 0.04). This is significantly more frequent that the HPV contamination among healthy individuals, which was 28.7% (р = 0.02). Mixed association of β-HPV was also more frequent in the HPV-positive patients (21/24, or 83.3%; compared to the control group, р = 0,00001). The maximal (significant) viral load was found in the subgroup of seborrheic keratosis patients with the number of proliferative lesions of 10 and more (4.08 ± 0.3 lg/105 tо 5.7 ± 0,3 lg/105). Conclusion: The maculopapular type of seborrheic keratosis is characterized by mixed HPV β1, β2, β3 infection found in 77.7% of cases irrespective of the number of proliferative lesions. It could be hypothesized that multiple seborrheic keratosis (more than 10 lesions) develops in simultaneous presence of HPV β1, β2, β3 and is associated with a  higher probability of new seborrheic keratosis lesions on intact skin. 

About the authors

T. P. Pisklakova

South Ural State University (National Research University)

Author for correspondence.
Email: pisklakova@mail.ru

Pisklakova Tatiana P. – MD, PhD, Professor

6–188 Yuzhny bul'var ul., Chelyabinsk, 454135

Россия

E. I. Kostenko

Chelyabinsk Regional Clinical Skin-Venereal Dispensary No. 3

Email: fake@neicon.ru

Kostenko Elena I. – MD, Dermatovenereologist, the Head of Skin Department 

35 Zhukova ul., Chelyabinsk, 454031

Россия

L. F. Telesheva

South Ural State Medical University

Email: fake@neicon.ru

Telesheva Larisa F. – MD, PhD, Professor, Vice-rector for Science, Innovation and International Relations 

64 Vorovskogo ul., Chelyabinsk, 454092

Россия

References

  1. Ламоткин ИА. Клиническая дерматоонкология: атлас. М.: БИНОМ: Лаборатория знаний; 2011. 499 с.
  2. Молочков ВА, Киселев ВИ, Рудых ИВ, Щербо СН. Папилломавирусная инфекция: клиника, диагностика, лечение. М.: Студия «Мирада Вива»; 2005. 30 с.
  3. Pollitzer S. Die seborrhoische Warze. Monatshefte für praktische Dermatologie. 1890;11:147–55.
  4. Головин ДИ. Эпителиальные опухоли кожи (классификация, гистология и гистогенез). Кишинев: Госиздат Молдавии; 1958. 151 с.
  5. LeBoit PE, Burg G, Weedon D, Sarasain A, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006. 355 p.
  6. Hafner C, Vogt T, Landthaler M, Müsebeck J. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses. Br J Dermatol. 2008;159(1):214–7. doi: 10.1111/j.1365-2133.2008.08626.x.
  7. Alapatt GF, Sukumar D, Bhat MR. A clinicopathological and dermoscopic correlation of seborrheic keratosis. Indian J Dermatol. 2016;61(6): 622–7. doi: 10.4103/0019-5154.193667.
  8. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN; Leiden Skin Cancer Study. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120(6):1087–93. doi: 10.1046/j.1523-1747.2003.12246.x.
  9. Gill D, Dorevitch A, Marks R. The prevalence of seborrheic keratoses in people aged 15 to 30 years: is the term senile keratosis redundant? Arch Dermatol. 2000;136(6):759–62.
  10. Requena L, Kutzner H. Seborrheic keratosis with pseudorosettes and adamantinoid seborrheic keratosis: two new histopathologic variants. J Cutan Pathol. 2006;33 Suppl 2:42–5. doi: 10.1111/j.1600-0560.2006.00528.x.
  11. Kwon OS, Hwang EJ, Bae JH, Park HE, Lee JC, Youn JI, Chung JH. Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed. 2003;19(2):73–80. doi: 10.1034/j.1600-0781.2003.00025.x.
  12. Ламоткин ИА, Малиновский НА. О клинике и лечении себорейного кератоза. Военно-медицинский журнал. 2010;331(2):72.
  13. Молочков ВА, Давиденко ЕБ, Зенкевич ЕВ. Случай сочетания вульгарной пузырчатки и гигантского акантолитического себорейного кератоза. Российский журнал кожных и венерических болезней. 2012;(5):29–32.
  14. Мяделец ОД, Адаскевич ВП. Морфофункциональная дерматология. М.: Медицинская литература; 2006. 752 с.
  15. Кладова АЮ, Куевда ДА, Молочков ВА, Шипулина ОЮ, Киселев ВИ, Хлебникова АН, Козлова ЕС. Встречаемость кожных типов вируса папилломы человека в патологиях кожи. Альманах клинической медицины. 2006;9:44–50.
  16. Кладова АЮ, Куевда ДА, Шипулина ОЮ, Киселев ВИ, Молочков ВА. Разработка и апробация количественного метода определения концентрации бета-папилломавирусов в коже. Молекулярная медицина. 2007;(4): 33–40.
  17. Jackson JM, Alexis A, Berman B, Berson DS, Taylor S, Weiss JS. Current understanding of seborrheic keratosis: prevalence, etiology, clinical presentation, diagnosis, and management. J Drugs Dermatol. 2015;14(10):1119–25.
  18. Squillace L, Cappello M, Longo C, Moscarella E, Alfano R, Argenziano G. Unusual dermoscopic patterns of seborrheic keratosis. Dermatology. 2016;232(2):198–202. doi: 10.1159/000442439.
  19. Roh NK, Hahn HJ, Lee YW, Choe YB, Ahn KJ. Clinical and histopathological investigation of seborrheic keratosis. Ann Dermatol. 2016;28(2): 152–8. doi: 10.5021/ad.2016.28.2.152.
  20. Duque MI, Jordan JR, Fleischer AB Jr, Williford PM, Feldman SR, Teuschler H, Chen GJ. Frequency of seborrheic keratosis biopsies in the United States: a benchmark of skin lesion care quality and cost effectiveness. Dermatol Surg. 2003;29(8):796–801. doi: 10.1046/j.1524-4725.2003.29211.x.
  21. Кравец НВ. Клинико-иммунологические особенности папиллом кожи, ассоциированных с суперинвазивным описторхозом. Российский журнал кожных и венерических болезней. 2012;(3):4–7.
  22. Белоусова ТА, Горячкина МВ. Папилломавирусная инфекция кожи и слизистых оболочек. Фарматека. 2010;(1):32–6.
  23. Файзуллина ЕВ. Папилломавирусная инфекция: современная точка зрения. Экспериментальная и клиническая дерматокосметология. 2011;(1):58–64.
  24. Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M; EPI-HPV-UV-CA Group. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol. 2009;90(Pt 8):1986–98. doi: 10.1099/vir.0.010637-0.
  25. Рахматулина МР, Нечаева ИА. Иммунотропная терапия детей с папилломавирусной инфекцией препаратом ликопид. Вестник дерматологии и венерологии. 2009;(6): 109–12.
  26. Stanley M. Chapter 17: Genital human papillomavirus infections – current and prospective therapies. J Natl Cancer Inst Monogr. 2003;(31): 117–24.
  27. Choi HJ, Lee JH. Multiple human papilloma virus 16 infection presenting as various skin lesions. J Craniofac Surg. 2016;27(4):e379–81. doi: 10.1097/SCS.0000000000002642.
  28. Wu YH, Hsiao PF, Chen CK. Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its association with human papillomavirus infection. Am J Dermatopathol. 2015;37(6):462–8. doi: 10.1097/DAD.0000000000000285.
  29. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, Forslund O, Pawlita M, Dillner J. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev. 2008;17(1):189–95. doi: 10.1158/1055-9965.EPI-07-0405.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pisklakova T.P., Kostenko E.I., Telesheva L.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies